 |
05-May-08: Insilicos Awarded Grant for Life Science Computing 03-Apr-08: Insilicos Wins NIH Grant for Manufacturing 14-Jan-08: Insilicos Heart Disease Project Wins Research Funding 30-Aug-07: Insilicos Awarded $1 Million Grant for Biotech Services 30-Apr-07: Insilicos Names Heinecke to Chief Medical Advisor Post 22-Sep-06: Insilicos and GeneBio Sign Global Distribution Agreement 29-May-06: Insilicos Announces Breakthrough Proteomics Software Platform 28-Mar-06: Insilicos Announces 1000th Licensed User of InsilicosViewer 13-Mar-06: Insilicos Awarded Grant to Study Heart Disease 14-Feb-06: Insilicos CEO Erik Nilsson Interviewed 06-Feb-06: Insilicos Awarded Grant to Commercialize Proteomics Research 14-Sep-05: Insilicos announces support for biotech data format 31-Aug-05: Insilicos Announces Web Support for Biotech Tools 08-Jul-05: Insilicos appoints Teresa Skarr as Director of Regulatory Affairs 04-Jun-05: Insilicos Announces 500th Licensed User of InsilicosViewer 27-Apr-05: Insilicos Presents at Invest Northwest 31-Mar-05: Insilicos releases new version of viewer 23-Feb-05: Insilicos Awarded Proteomics Grant 14-Dec-04: Ruedi Aebersold joins Insilicos Advisory Board 01-Sep-04: InsilicosViewer in the News 15-Apr-04: Insilicos Wins NIH Grant 13-Oct-03: Insilicos Releases Beta 26-Jun-03: Insilicos Wins Grant 30-Sep-02: Insilicos Platform Project Announced
| |
|
Insilicos Announces Breakthrough Proteomics Software Platform
|
|
Seattle, 29 May 2006: Seattle life sciences company Insilicos today announced the launch of Insilicos Proteomics Pipeline (IPP), the first high-performance software system for the identification and analysis of proteomics data. Proteomics is a key technology behind the development of new biotech drugs and diagnostic tests.
IPP is the result of an open-source collaboration led by the Institute for Systems Biology (ISB). "This offering by Insilicos will allow more people to take advantage of the proteomics approaches that we pioneered at the Institute for Systems Biology," said ISB cofounder and internationally renowned biologist Dr. Ruedi Aebersold. "The performance and ease of use of this product is a significant advance, and will contribute to the goal of consistent and transparent analysis of proteomics data."
Insilicos developed IPP as a result of its role as the leading outside contributor and collaborator on the ISB's proteomics project. IPP takes the groundbreaking work of the ISB, and makes it run up to 20 times faster —fast enough to run on an inexpensive laptop. "Proteomics will revolutionize human health, but software has been a key bottleneck," said Insilicos president Erik Nilsson. "Now IPP brings that power within reach of anyone with a laptop."
The ISB originally developed the Trans-Proteomic Pipeline tools as part of a grant funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. In 2005, Insilicos and the ISB received a grant from the NHLBI to further develop the ISB's software for use by a broad range of scientists.Insilicos LLC develops life science software for pharmaceutical development, biological research and clinical diagnostics.
For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' and 'Life Science Software' are trademarks of Insilicos LLC.
|
|
